r/senseonics • u/margi2 • Jun 11 '21
r/senseonics • u/akuseru1994 • Jan 26 '21
r/senseonics Lounge
A place for members of r/senseonics to chat with each other
r/senseonics • u/BlackRockTime • Jun 13 '21
catalyst $SENS is now the 3rd most discussed stock of the week! So let´s take SENS back to where it belongs.
r/senseonics • u/choiph • Jun 04 '21
Upvote to get more awareness for the company and news.
Hey guys, we should upvote this post to get more awareness. It's a good company has been constantly shorted and now it has a promising results. Next dexcom in the making I swear.
r/senseonics • u/True_Demon • Jun 26 '21
catalyst Something might be happening with $SENS this weekend
Hey. Short DD here on $SENS (Senseonics Holdings Inc.)
Something caught my attention at the close of the day. $SENS had 81M shares in trading volume today according to WeBull; however, because of this post which called attention to a massive volume spike at precisely 3:59PM EST that caused 41M shares to exchange hands in the last minute of the day.

Naturally, we can speculate this was a market-on-close (MOC) order, which the exchange facilitates at precisely the end of the day in order to execute an at-the-market order at or after the day's close in order to guarantee execution, regardless of price.
We can easily speculate that $SENS being added to the Russell 3000 is the major cause; however, that isn't all...
I've been following Senseonics, and specifically watching its options chain very closely ever since February. I speculated in April that a gamma squeeze would be on the horizon due to catalyst news following $SENS's latest clinical trial studies and their partnership with Ascensia bringing in new revenue, plus the pandemic finally coming to a close.
Well... I'm either clairvoyant, lucky, or I happen to have a few wrinkles in my brain, but I was right.
The options chain on SENS in April was over 130K OI on call options between April, June and July. Beginning on June 4th, the day after $AMC's gamma squeeze to $70 ATH, $SENS also experienced a gamma squeeze prompted by a volume spike of more than 100 million shares bought in the first half of the day. This momentum carried $SENS to a high of $4.80, just below $5 where more than 80K calls would have been in the money before it was sent tumbling back down by a massive influx of short interest that sent $SENS back to a low of $3.00. At that time, SI was over 35% and has since continued to climb to 40%.
Open Interest on $SENS calls evaporated after the gamma squeeze calmed down, and traders took huge profits. Now SENS is rebounding again, culminating in series of massive call sweeps at every single date between now and January 20th, 2023. Benzinga reported multiple call sweeps of enormous proportions back on June 10th, but all of them were dwarfed by $SENS's OI on $10 leaps for January 2023 and near-the-money calls for July 16th between $3 and $5. (Options chain)
That's not all. There is something else going on this weekend as well.
The American Diabetes Association (ADA) is hosting its 81st annual virtual conference on the latest discoveries, treatments, and technologies, including a 15 minute time-slotted talk from the Senseonics scientific and leadership team which has been heading the clinical trials on the Eversense XL 180-day CGM. They already announced the success of their PROMISE study publicly to the world... but something feels different about this conference.
This product, which is revolutionary in its capabilities and performance as the first long-term implantable Continuous Glucose Monitor, has been waiting for FDA approval for close to 3 years. In its February Q1 earnings statement, the $SENS board members acknowledged during questions that, "the FDA has now assigned a top reviewer to our PMA supplement application for the submitted 180 day Eversense product." [source]

The ADA2021 scientific sessions is closed to all but members of the scientific community and therefore nobody in the public media will be reporting anything that takes place here at these sessions. Note that the ADA meeting is specifically mentioned in the Q1 earnings call back in February, and regulatory approval of the Eversense aligns with the independent trial studies conducted on the Eversense 180-day CGM, which is the PROMISE study and showed enormously successful results.

I strongly doubt this is a coincidence.
I have been saying ever since March that Senseonics could see FDA approval as early as July, if things played out correctly. With every single clinical trial study's success, I grew more convinced, and as of the success of the PROMISE study, I am absolutely convinced that $SENS has secured FDA approval, and is just waiting for the right time to announce it.
The $SENS team is delivering their discoveries at 8:30AM on Sunday per the ADA2021 program
The fact that this event coincides with the announcement and execution of $Senseonics' addition to the Russell 3000, the results of their Eversense XL 180-day CGM "PROMISE Study", plus a massive MOC order of 40 Million shares at the end of the day, making up more than 50% of its daily volume is absolutely not a coincidence. Oh yeah... and the short interest is still over 31%, did I mention that?

If you want to read up on my other DD, you can check out "My last yolo" DD series on Senseonics to catch up. There are 6 in total, so a bit of a long read but worthwhile, I promise.
Maybe I'm wrong, and maybe FDA approval is still a long ways off, but if I'm right, you'll wish you had $SENS on your watchlist.
**Disclosure:** I hold a significant investment in $SENS in both stock and call options. I'm not a financial advisor and this is not financial advice. Be responsible with your money and don't base your financial decisions off the ramblings of a random dude in sunglasses on Reddit.
TL;DR: One or several big dick-swinging whales just picked up more than 30,000 call options between this June and January 2023, bought 40M shares at the last minute of the day (50% day's volume), betting that $SENS is going to blow through the stratosphere the day $SENS was being added to the Russell 3000 and two days before their big **private** presentation at the American Diabetes Association Scientific Sessions while we are waiting on FDA approval to ignite the $SENS rocket.
Oh, and $SENS just hit $3.95 after hours... Use your wrinkles and do some math.
r/senseonics • u/LengthinessPale2958 • Feb 12 '21
DD All 728 Members - Final Push Today !!! Please Upvote this sub reddit post https://www.reddit.com/r/trakstocks/comments/lek6nc/sens_dd_huge_upside/
If you Love $SENS, Please UpVote below post under DeadNSyde subbreddt by this Saturday.
If SENS becomes the Top upvoted post of this week, DeadNSyde will make a video on it early next week. All the stocks get great traction and love after he makes the video. lookup BNGO, CPSH, UAVS, etc.
Lets get 500 upvotes there!
https://www.reddit.com/r/trakstocks/comments/lek6nc/sens_dd_huge_upside/
Here is DeadNSyde's Youtube channel. He is an Absolute Gem!
r/senseonics • u/Anderson9520822 • Jun 11 '21
I have a feeling we’re going to see this group get much bigger in the coming months. Congrats to everyone who knew the stock did their DD and HELD.
r/senseonics • u/Emergency-JT1984 • Jun 17 '21
True cost and why SENS will succeed. This costs 5k a month
r/senseonics • u/Horseplayer21 • Jun 16 '21
Please remember SENS has FDA approval pending…This stock is going to the MOON!!!
r/senseonics • u/thrashsynergy • Jun 10 '21
Senseonics DD
Prefacing this with I know everyone in this sub is probably aware of all of this already; but I spent too much time and energy writing this on WSB for it to get a few upvotes and removed by mods there. Let me know your thoughts!
This is my first go at this, so buckle the fuck up for some good old fashioned research and analysis with a healthy dose of speculation.
Who is Senseonics
Senseonics ($1.5bn Market Cap) is in the Continuous Glucose Monitoring - CGM - business. The goal of CGM products are to, eventually, eliminate the need for finger sticks and provide peace of mind to diabetics by monitoring a patients glucose levels through a sensor inserted under the skin which relays information to an app.
Their leadership team is highly educated and highly experienced, with their CMO having spent over 40 years in diabetes research & care alone.
Competitive Landscape
The two primary competitors in this sector are Dexcom ($38.6bn) & Abbott Labs ($195.7bn), although for comparison purposes Dexcom is much closer to a CGM pure play.
Dexcom's product, the G6 needs to be changed out every 10 days and suffers from issues with accuracy and losing signal, on top of being prohibitively expensive without great insurance coverage.
Abbott's Freestyle Libre lasts for 14 days and is much cheaper, but also suffers from accuracy issues as well as users frequently complaining about the sensor falling off.
Senseonic's Product
Senseonics has the opportunity to disrupt this space with the longevity and accuracy of its Eversense product. In the United States, the 90 day version of Eversense is already available, with the 180 day (Eversense XL) already being distributed in Europe and a 365 day in the pipeline (3+ years).
The Eversense XL is currently in the FDA approval process; it was expected in Q1 of this year, but was delayed due to COVID and is currently slated for approval in Q3, with most of the speculation being that October is the most likely date.
The major drawback to the Eversense is that it must be surgically inserted in a 30 minute outpatient procedure.
Recent Catalyst
What we all came for; why the sudden price action?
The primary catalyst is the publication of a PROMISE study that shows that the Eversense's primary sensors are as accurate as both the G6 and Libre, with a secondary modified sensor drastically out-performing both, and with no serious complications in any patients. The speculation is that this could expedite the FDA approval process, but at the very least confirms that the technology is sound.
Obviously FDA approval of the 180 day Eversense XL would be huge; but behind the scenes Senseonics has slowly but surely increasing the insurance coverage of its product line and hopes to increase market share through a partnership with Ascensia. Not only has Ascensia provided significant financial backing to Senseonics to stimy any liquidity issues (with additional funding contingent on 180 day approval), they have agreed to take on the US sales & marketing of Eversense products.
The secondary catalyst is the publication that Senseonics will be added to the Russell 3000 on June 25th. Institutions have already steadily been increasing their holdings, but addition to a major index invites even more to round out their holdings.
Future Outlook
Diabetes is not going anywhere; according to the ADA the number of diabetics worldwide is projected to increase to 4.4% of the population in 2030, up from 2.8% in 2000. If there is any merit to the recent data that suggest COVID may cause diabetes, this number could be even greater. This suggest that the "pie" being sliced between Senseonics, Dexcom and Abbott will continue to grow.
Dexcom provides the most comparable platform in terms of accuracy (accurate enough for insulin dosing without finger sticks), with a product that only lasts 10 days and a whole host of issues such as dropping signal and an extremely annoying audible alert. With this product as their flagship, Dexcom generated over $500 million in revenue during Q1 alone, according to their 10-Q, and currently sits at a market cap of $38.6 billion.
A more accurate, affordable and, most importantly, longer lasting Eversense XL could easily eat into that market share. Exactly how much remains to be seen; however, with a superior product and a rapidly growing population of diabetics, a $10bn valuation (roughly a quarter of Dexcom's) does not seem out of the question. That would imply a roughly 6.67x increase in Senseonics current share price in relatively short order. With FDA approval, I would honestly be shocked to see anything less than $10 per share by EOY. I would also not be shocked to see an acquisition of this company with a valuation between $8-12 billion.
Squeeze-ability
I feel like this is an obligatory WSB section at this point; personally, I have been accumulating as a long term hold and I am in no way advocating YOLO'ing the rent money on this.
However, there is certainly potential if this were to gain any traction.
From the gamma squeeze perspective, the highest strike June 18 call is $4... at time of writing, $SENS was sitting at $3.96. Additionally, the highest strike available for later dates is $10... which you may recall is highly likely given FDA approval. A $10bn valuation or buyout would imply a share price of nearly $24, which makes some of those leaps look incredibly juicy.
From the short squeeze perspective, short % of the free float has INCREASED since the most recent pop from 20% to nearly 33% at time of writing.
I don't think anyone on this sub needs a reminder of what can happen when the powers of gamma and short squeeze combine.
Full Disclosure, I have 43,700 shares at a 2.15 cost average, and I intend to continue accumulating 100 share blocks periodically until FDA approval. I am absolutely not a financial advisor, please do your own research and come to your own conclusions.
Also as I was proofreading this, another Sens DD popped up - More of the same but goes deeper into Ascensia's impact (https://www.reddit.com/r/wallstreetbets/comments/nwzmjz/sens_32_shorted_can_be_a_10x_candidate_from_here/)
TL;DR
SENS has a game changing product on their hands, with FDA approval imminent and increasingly likely after promising study results. Possibly organic 10x'er within 3-5 years, with extreme momo and squeeze potential with 33% free float short, highest strike weekly calls only .10 cents OTM in AH, and highest strike leap calls just over $6 OTM.
r/senseonics • u/Adapt_Fitness • Apr 05 '22
discussion Hey all! My name is Chris and I was the first patient to get the 180 day sensor! AMA about it or why I think it’s the best cgm on the market
r/senseonics • u/Runitup-21 • Jun 24 '21
catalyst $SENS is about to explode!!!
Management are giving a presentation with the update on the 180-day trial on Sunday morning (June 27th)!!! Longgggg
r/senseonics • u/twilson234 • Mar 11 '21
Why I’m all in SENS
My 10 year old daughter has type 1 diabetes and has been in the dexcom system for the last 3 years. While I like the dexcom peace of mind, it is a frustrating product. The sensor is FDA approved for 10 days. We typically get about 6 days before the sensor dies. If it dies within that 10 days we get a free replacement. I now have a 6 month supply of this product due to sensor issues. That means every 6-7 days my daughter has to inject the dexcom sensor into her skin, which she doesn’t mind too much. She hates taking the old one off as it rips her skin every time and she screams. The last days for a sensor are very inaccurate. Just last night I was awaken from a phone call at 2am alerting me of her falling BS. It said 70 going double down. Anytime you see this you panic as it is life threatening. Knowing we were having sensor errors earlier in the day I decided to do a finger poke. Real reading was 185 not the best but good sleep number for a kid and definitely not life threatening. We have been watching the progression of the senseonisc for the past 2 years on various FB forums. The excitement is real for this product. I have read many comments about people not wanting to go through the implant process on investing forums. To them I would say type 1’s are use to needles, finger pricks and pokes. They are the toughest SOBs around and would not let a little incision stop them from this if they get a 6 month wear. Long story short, this product can overtake dexcom in the future in my opinion. Look at their board of directors and that gives me even more reason to be optimistic. I’m long SENS and not worried one bit!
r/senseonics • u/Pitiful-Meringue-564 • Jun 14 '21
stock price $4.76 spike in the premarket. Could be a good day boys and girls!
r/senseonics • u/powerlock84 • Feb 11 '22
discussion Sign from God. Lol
I'm at cvs getting my scripts 20 min ago. There was an old man over 70 infront of me driving me nuts he was so slow. But I held my cool and was nice. We both get up there. The lady says, I got your sensor no problem. I asked him what sensor. He said the g6. I said oh okay. Then he said, can't wait to switch. I said from the g6? He said yeah, he had bad ones and the adhesive really bothers his skin. He told me he is waiting for this sensor called the eversense, it goes in my arm he said. But he wants the 180 day, but its not approved yet. I said, no it got approved today. He was happy to hear and thanked me. That right there is a sign from God. Lol
r/senseonics • u/The_Brand94 • Jun 29 '21
discussion $SENS makes sense.
Short term by EOY or long term or potentially squeeze worthy, I believe in SENS. I yolo’d $20K into SENS and I don’t care. Stonks only go up. All my magic eight ball said is to hodl and wait. All my DD told me to do is hodl and wait. All my smooth brain told me to do is hodl and wait.
SENS is free money. When FDA approval hits it will send it up another 50-100% and I hope that’s enough to scare the shorts out of their money. There is no reason to believe this company would fail. They will compete with the likes of Dexcom, Abbott, and Medtronic. It’s inevitable that it will clap the metaphorical cheeks of diabetes.
$SENS 🚀 🚀 🚀 ⬆️⬆️⬆️⬆️🌖🌗🌖
r/senseonics • u/[deleted] • Jul 05 '21
Positive vibes Bullish AF
A lot of FUD going around that I can only attribute to fear, and someone trying to drive SENS into the ground. Ive had a lot of opportunity in my face that I passed on because I didnt have the capital at the time. For example, tesla at $28 per share in 2010’ish and hoping it came down to $20. Bitcoin at $56. The list goes on. Im not missing this train. Do your worst shorts. Im long 42,400 shares, and holding for years now. This is a game changer. I talked to a friend who has a son with T1D and autism. They have trouble every day with dexcom due to the sensor getting ripped off. A 5 minute procedure alleviates replacing 10+ sensors for them. The app lets the father track his sons blood sugar as needed. Im all in. See ya’ll at $20+. Rant over.